Ats Corporation · TSX:ATS
Ats — Q2 2025 Earnings Presentation
15 slides from Ats's earnings presentation, Nov 6, 2024
Slide 1: Q2 2025 Earnings Call
Q2 2025 Earnings Call November 6, 2024 8:30am ET
Slide 2: Today's Hosts
Today's Hosts Andrew Hider Ryan McLeod Chief Executive Officer Chief Financial Officer
Slide 3: Forward Looking Statements
Forward Looking Statements Note to Reader: This presentation and the oral statements made during this call contain certain statements that may constitute forward-looking information and forward-looking statements within the meaning of applicable Canadian and United States securities laws ("forward-l
Slide 4: Non-IFRS and Other Financial Measures
Non-IFRS and Other Financial Measures Throughout this presentation management uses certain non-IFRS financial measures, non-IFRS ratios and supplementary financial measures to evaluate the performance of the Company. The terms “EBITDA”, “organic revenue”, “adjusted net income”, “adjusted earnings fr
Slide 5: Q2 2025 & Recent Highlights
Q2 2025 & Recent Highlights Order Bookings1 led by record quarterly bookings within life sciences ▪ Q2 Order Bookings¹ flat y/y at $742MM as strong life sciences Order Bookings offset expected lower EV Order Bookings ▪ Q2 Revenues down ~17% y/y to $612.8MM on expected lower EV revenues ▪ Q2 Adj. Ear
Slide 6: Outlook
Outlook Order Backlog1 provides good revenue visibility: • Life Sciences $1,132MM: funnel remains strong, opportunities to leverage full breadth of capabilities • Food and Beverage $210MM: funnel remains strong; supported by Paxiom acquisition • Energy $109MM: funnel remains strong and includes long
Slide 7: Financial Results
Financial Results Y/Y Y/Y Y/Y Y/Y (C$ mm, except per share Q2 Q2 Change Change F2025 F2024 Change Change data) F2025 F2024 ($) (%) ($) (%) Revenues $612.8 $735.7 $(122.9) (16.7)% $1,307.1 $1,489.4 $(182.3) (12.2)% Revenue Growth: QTR YTD Earnings from operations 22.2 83.0 (60.8) (73.3)% 89.8 162.1 (
Slide 8: Summary
Summary ▪ Strong, diversified Order Backlog1 provides good revenue visibility ▪ Estimated Q3-F25 revenue range of $620 million to $680 million ▪ Expect short-term margin pressures from lower transportation revenues to reduce as we complete our reorganization activities and drive growth in the rest o
Slide 9: ATS
ATS
Slide 10: WATS
WATS
Slide 11: Appendix: Measures
Appendix Reconciliation of Non-IFRS Measures to IFRS Measures 11
Slide 12: Appendix: Reconciliation of Non-IFRS Measures to IFRS Measures
Appendix: Reconciliation of Non-IFRS Measures to IFRS Measures The following table reconciles adjusted EBITDA and EBITDA to the most directly The following table reconciles organic revenue to the most directly comparable IFRS comparable IFRS measure (net income) (in millions of dollars): measure (re
Slide 13: Appendix: Reconciliation of Non-IFRS Measures to IFRS Measures
Appendix: Reconciliation of Non-IFRS Measures to IFRS Measures The following table reconciles adjusted earnings from operations to the most The following table reconciles adjusted basic earnings per share to the most directly comparable IFRS measures (net income) (in millions of dollars): directly c
Slide 14: Appendix: Reconciliation of Non-IFRS Measures to IFRS Measures
Appendix: Reconciliation of Non-IFRS Measures to IFRS Measures The following table reconciles net debt to adjusted EBITDA to the most directly The following table reconciles free cash flow to the most directly comparable comparable IFRS measure (in millions of dollars): IFRS measure (in millions of
Slide 15: Appendix: Reconciliation of Non-IFRS Measures to IFRS Measures
Appendix: Reconciliation of Non-IFRS Measures to IFRS Measures The following table reconciles the previously reported non-IFRS financial measures to reflect the exclusion of the stock-based compensation revaluation expenses: (C$ mm) Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 F2023 F2023 F2024 F2024 F2024 F2024 F2025 F
ATS Corporation Common Shares — Q2 2025 Earnings Presentation on 6ix